RECQL4 antibody (B-3) is a mouse monoclonal IgM kappa antibody developed for detecting the RECQL4 protein across species, including humans, mice, and rats. It is widely used in techniques such as:
Western blotting (WB)
Immunoprecipitation (IP)
Immunofluorescence (IF)
Enzyme-linked immunosorbent assay (ELISA)
This antibody targets RECQL4, a member of the RecQ helicase family critical for DNA replication and repair .
DNA Repair Mechanisms: RECQL4 interacts with PARP1 to facilitate DNA double-strand break (DSB) repair via alternative non-homologous end joining (alt-NHEJ). PARP1 recruits RECQL4 to damage sites and enhances its DNA strand annealing activity .
Cancer Relevance:
Disease Link: Mutations in RECQL4 cause Rothmund-Thomson syndrome, characterized by skeletal defects and cancer predisposition .
RECQL4 displaces replication protein A (RPA) from single-stranded DNA (ssDNA) to promote microhomology annealing during alt-NHEJ .
Helicase-inactive RECQL4 mutants retain annealing capabilities, indicating separable functional domains .
Biomarker Potential: Elevated RECQL4 levels in TNBC may serve as a predictive marker for cisplatin resistance .
Therapeutic Targeting: Inhibiting RECQL4-PARP1 interactions could sensitize cancer cells to DNA-damaging agents .
"RECQL4’s annealing activity, distinct from its helicase function, provides a novel target for disrupting error-prone DNA repair pathways in cancer."
RECQL4 antibodies are widely employed across several experimental applications with varying recommended dilutions:
| Application | Recommended Dilution | Notes |
|---|---|---|
| Western Blot (WB) | 1:1000-1:5000 | Detects 145-150 kDa band in human samples |
| Immunoprecipitation (IP) | 0.5-4.0 μg per 1-3 mg lysate | Effective in HeLa cell lysates |
| Immunohistochemistry (IHC) | 1:50-1:500 | May require antigen retrieval with TE buffer pH 9.0 |
| Immunofluorescence (IF/ICC) | 1:200-1:800 | Successful in detecting nuclear and mitochondrial localization |
| Immunofluorescence (IF-P) | 1:50-1:500 | For paraffin-embedded sections |
When selecting an application, consider that RECQL4 shows both nuclear and mitochondrial localization. Multiple studies have confirmed RECQL4's presence in mitochondria using various antibodies from different vendors, with coefficients of co-localization with MitoTracker Red ranging from 0.128 to higher values in perinuclear regions .
Selection should be based on:
Target region specificity: Different antibodies target distinct domains of RECQL4:
N-terminal antibodies (AA 1-652): Detect the Sld2-like domain critical for DNA replication
C-terminal antibodies (AA 1134-1162): Recognize the region containing the helicase motifs
Internal region antibodies (AA 200-337): Target conserved regions
Experimental validation: Choose antibodies with published validation in your application of interest. For example, antibodies verified in RECQL4 knockdown/knockout models provide greater confidence in specificity .
Host species compatibility: Consider the host species (rabbit, mouse) when designing multiplex staining experiments to avoid cross-reactivity.
Reactivity with target species: Verify that the antibody has been validated in your species of interest (human, mouse) .
Proper validation is essential to ensure experimental rigor:
Positive controls: Use cell lines known to express RECQL4 (HeLa, HepG2) .
Knockdown/knockout validation:
Molecular weight confirmation: Verify that detected bands match the expected molecular weight of RECQL4 (calculated: 133 kDa; observed: 145-150 kDa) .
Multiple antibody confirmation: Use antibodies targeting different epitopes to confirm specificity. Studies have employed antibodies from Sigma, Santa Cruz, and custom sources with consistent results .
RECQL4 is rapidly recruited to DNA double-strand breaks (DSBs). To study this phenomenon:
Laser microirradiation approach:
Use confocal laser scanning microscopy with calibrated laser settings
At >10% laser intensity, both single-strand breaks (SSBs) and DSBs are produced
RECQL4 recruitment can be observed within 5 seconds after microirradiation
Co-stain with γ-H2AX to confirm DSB induction and 53BP1 as a DSB repair factor
Live-cell imaging with GFP-RECQL4:
Key controls:
RECQL4 interacts with several key DNA repair proteins. To study these interactions:
Co-immunoprecipitation protocol:
Prepare cell extracts with RIPA buffer containing protease inhibitors
Add benzonase (0.1 U/μl) with 1 μM Mg²⁺ to eliminate DNA-mediated interactions
Use 100-200 μg of clarified lysate with anti-RECQL4 antibody or anti-tag antibody
Include IgG control to assess non-specific binding
Wash beads with high salt (500 mM NaCl) followed by IP buffer washes
For PARP1 interaction studies, also perform reciprocal IPs with anti-PAR antibody
In vitro protein interaction assays:
Enhanced detection in specific cell cycle phases:
RECQL4 undergoes several post-translational modifications, particularly PARylation by PARP1:
Detection of PARylated RECQL4:
Mapping modification sites:
Functional impact assessment:
RECQL4 can be challenging to detect due to its size (145-150 kDa) and variable expression levels:
Sample preparation optimizations:
Gel and transfer considerations:
Use 4-15% gradient SDS-PAGE gels for optimal separation
Consider longer transfer times (overnight at lower voltage) for high molecular weight proteins
Validate transfer efficiency with Ponceau staining
Antibody dilution and incubation:
Detection systems:
When studying the effects of RECQL4 depletion:
Knockdown approaches and validation:
siRNA transfection: Use 100 pmol of RECQL4-targeted siRNA (sequence: CAAUACAGCUUACCGUACA) with Lipofectamine 2000
For more efficient knockdown, perform sequential transfections 24 hours apart
Always include non-targeting siRNA controls (e.g., ON-TARGET plus non-targeting siRNA #1, Dharmacon)
Verify knockdown by both western blotting and qPCR (expect ~90% reduction)
Experimental controls for functional studies:
Include both wild-type cells and cells with other RecQ helicase knockdowns (BLM, WRN) for comparison
For rescue experiments, use RECQL4 constructs resistant to siRNA targeting
Include helicase-dead mutants (K508A) to distinguish helicase-dependent functions
When investigating RECQL4-BLM cooperation, examine both single and double knockdowns
Phenotypic assays to verify knockdown effects:
RECQL4 possesses several biochemical activities that can be measured:
Helicase activity assay:
Use radiolabeled fork duplex substrates (0.5 nM concentration)
Reaction buffer: 30 mM Tris-HCl pH 7.4, 50 mM KCl, 5 mM MgCl₂, 1 mM DTT, 100 μg/ml BSA, 10% glycerol, 5 mM ATP
Incubate for 30 minutes at 37°C
Analyze by 10% native PAGE electrophoresis
Note: RECQL4 has weak helicase activity often masked by its strand annealing activity
Use short fork duplex DNA oligonucleotides to better visualize helicase activity
Strand annealing assay:
Use complementary oligonucleotides with one strand 5'-end labeled with [γ-³²P] ATP
Reaction buffer: 30 mM Tris-HCl pH 7.5, 50 mM KCl, 1 mM DTT, 5 mM MgCl₂, 100 μg/ml BSA
Incubate for 10 minutes at 37°C
Analyze by 10% native PAGE
RECQL4 exhibits strong strand annealing activity that can be enhanced by PARP1
Replication protein A (RPA) displacement assay:
The helicase activity of RECQL4 has been debated in the literature:
Historical contradiction:
Technical solutions:
The strong strand annealing activity of RECQL4 can mask its helicase activity
Add excess single-stranded DNA to helicase reactions to visualize activity
Alternatively, use short fork duplex DNA substrates for direct detection without excess ssDNA
Optimize reaction conditions: 30 mM Tris-HCl pH 7.4, 50 mM KCl, 5 mM MgCl₂
Experimental approach to resolve contradiction:
RECQL4 exhibits context-dependent roles in cancer progression:
Contradictory observations:
Experimental approaches to resolve this contradiction:
Compare RECQL4 expression levels across cancer types using tissue microarrays
Correlate expression with patient outcomes in specific cancer subtypes
In melanoma, high RECQL4 expression limits survival and serves as an independent prognostic factor
In TNBC, high RECQL4 expression correlates with better response to cisplatin therapy
Mechanistic studies:
Investigate RECQL4 overexpression effects on RAD51 foci formation
Measure DSB levels using neutral comet assay in cells with RECQL4 overexpression
Assess the relationship between RECQL4 levels and tumor mutation burden
Examine correlation between RECQL4 expression and immune cell infiltration in tumors
Recent research has identified RECQL4 as a regulator of immune responses:
RECQL4 is unique among RecQ helicases in its significant mitochondrial localization:
Visualization approaches:
Fractionation methods:
Isolate mitochondria using differential centrifugation
Generate mitoplasts by digitonin treatment to remove outer membrane
Use markers for different compartments: VDAC (outer mitochondrial membrane), Cox IV (inner membrane), tubulin (cytosolic contamination)
Functional studies:
Measure mtDNA damage accumulation in RECQL4-deficient cells using Q-PCR
Perform microarray analysis to assess impact on mitochondrial bioenergetic pathways
Measure mitochondrial reserve capacity in RECQL4 knockdown cells
Investigate potential interaction between RECQL4 and mitochondrial DNA polymerase γ